OTC · CVSC
Consumer Cyclical · Personal Products & Services
$0.00
Up+$0.00 (+0.00%)
Updated Aug 23, 2026, 7:05 AM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
CVSC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning CVSC.
CVSC research
Company profile and research snapshot.
CARDIOVASCULAR SCI INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Jan 27, 2025
NMDPSM, a global nonprofit leader in cell therapy, announced executive leadership changes, including the appointment of Alexander Rosenstein as general counsel and chief compliance officer, and the expansion of Erica Jensen's role to include oversight of the NMDP Foundation.
GlobeNewswire Inc. · Nov 14, 2024
The report provides comprehensive information about the Peripheral Embolic Protection Devices pipeline products, including details on major pipeline products, key players involved, and ongoing clinical trials.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CVSC.
No results
No recent SID articles mention CVSC.
